GWN Securities Inc. Has $2.58 Million Holdings in The Clorox Company $CLX

GWN Securities Inc. cut its holdings in The Clorox Company (NYSE:CLXFree Report) by 33.2% during the second quarter, Holdings Channel.com reports. The firm owned 21,291 shares of the company’s stock after selling 10,581 shares during the quarter. GWN Securities Inc.’s holdings in Clorox were worth $2,578,000 as of its most recent SEC filing.

Other hedge funds have also added to or reduced their stakes in the company. Simplicity Wealth LLC grew its position in Clorox by 157.3% in the second quarter. Simplicity Wealth LLC now owns 18,316 shares of the company’s stock valued at $2,199,000 after purchasing an additional 11,198 shares in the last quarter. Raymond James Financial Inc. boosted its stake in shares of Clorox by 15.6% during the 1st quarter. Raymond James Financial Inc. now owns 269,926 shares of the company’s stock worth $39,747,000 after buying an additional 36,352 shares during the last quarter. OneDigital Investment Advisors LLC acquired a new position in shares of Clorox during the 1st quarter worth about $247,000. Bank of New York Mellon Corp boosted its stake in shares of Clorox by 1.3% during the 1st quarter. Bank of New York Mellon Corp now owns 826,158 shares of the company’s stock worth $121,652,000 after buying an additional 10,255 shares during the last quarter. Finally, Liberty One Investment Management LLC raised its holdings in Clorox by 2.9% during the first quarter. Liberty One Investment Management LLC now owns 201,741 shares of the company’s stock worth $29,706,000 after acquiring an additional 5,702 shares in the last quarter. Institutional investors own 78.53% of the company’s stock.

Wall Street Analyst Weigh In

Several analysts recently issued reports on the company. BNP Paribas Exane dropped their target price on Clorox from $118.00 to $110.00 and set an “underperform” rating on the stock in a report on Friday, October 17th. Barclays lowered their price target on Clorox from $118.00 to $112.00 and set an “underweight” rating on the stock in a research report on Tuesday, September 30th. Morgan Stanley decreased their target price on shares of Clorox from $150.00 to $137.00 and set an “equal weight” rating for the company in a research note on Friday, August 1st. Weiss Ratings reissued a “hold (c-)” rating on shares of Clorox in a research note on Tuesday, October 14th. Finally, Citigroup cut their price target on shares of Clorox from $135.00 to $130.00 and set a “neutral” rating for the company in a research note on Wednesday, October 8th. One research analyst has rated the stock with a Buy rating, twelve have given a Hold rating and four have issued a Sell rating to the stock. According to data from MarketBeat.com, Clorox currently has an average rating of “Reduce” and an average price target of $130.20.

View Our Latest Stock Analysis on Clorox

Clorox Trading Down 0.2%

Shares of Clorox stock opened at $115.59 on Tuesday. The business has a fifty day simple moving average of $121.10 and a two-hundred day simple moving average of $126.68. The Clorox Company has a 1 year low of $114.95 and a 1 year high of $171.37. The company has a market capitalization of $14.08 billion, a price-to-earnings ratio of 17.73, a P/E/G ratio of 0.96 and a beta of 0.52. The company has a debt-to-equity ratio of 5.15, a current ratio of 0.84 and a quick ratio of 0.57.

Clorox (NYSE:CLXGet Free Report) last issued its quarterly earnings data on Thursday, July 31st. The company reported $2.87 earnings per share for the quarter, beating the consensus estimate of $2.24 by $0.63. The company had revenue of $1.99 billion for the quarter, compared to analyst estimates of $1.94 billion. Clorox had a net margin of 11.40% and a return on equity of 377.86%. The company’s revenue was up 4.5% on a year-over-year basis. During the same period in the prior year, the firm earned $1.82 earnings per share. Clorox has set its FY 2026 guidance at 5.950-6.30 EPS. Research analysts forecast that The Clorox Company will post 7.15 EPS for the current year.

Clorox Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Thursday, November 6th. Investors of record on Wednesday, October 22nd will be paid a $1.24 dividend. The ex-dividend date is Wednesday, October 22nd. This represents a $4.96 dividend on an annualized basis and a yield of 4.3%. Clorox’s dividend payout ratio is 76.07%.

Insider Activity

In other news, COO Eric H. Reynolds sold 15,041 shares of the business’s stock in a transaction that occurred on Thursday, September 4th. The stock was sold at an average price of $123.78, for a total transaction of $1,861,774.98. Following the completion of the sale, the chief operating officer owned 54,221 shares in the company, valued at $6,711,475.38. The trade was a 21.72% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. 0.63% of the stock is currently owned by corporate insiders.

Clorox Company Profile

(Free Report)

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.

Featured Articles

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLXFree Report).

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.